Alpha Crest Capital Management LLC Alector, Inc. Transaction History

Alpha Crest Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $1.18 Million - $1.9 Million	144,190 Added 1386.44%	154,590 $1.46 Million
Q2 2022 Aug 11, 2022	SELL	$7.65 - $14.24 $137,409 - $255,778	-17,962 Reduced 63.33%	10,400 $106,000
Q1 2022 May 12, 2022	BUY	$13.02 - $20.78 $369,273 - $589,362	28,362 New	28,362 $404,000
Q4 2020 Feb 12, 2021	SELL	$9.4 - $16.7 $98,700 - $175,350	-10,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.54 - $24.96 $110,669 - $262,080	10,500 New	10,500 $111,000

161

59.8M

67.8K

200

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $358M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.